FDA 483 to Catalent Indiana Flags Inadeq
Novo Nordisk owned Catalent Indiana sterile products formulation facility was inspected by USFDA in June
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
